Showing results (41-50 of 1,827) with videos related to
Sort By:
Pageof 183
ESMO Open|January 3, 2026
Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapyI A Franken, F Heilijgers, M-C E Bakker, et al.ESMO Open|May 12, 2020
Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancerToshiki Masuishi, Hiroya Taniguchi, Takeshi Kawakami, et al.ESMO Open|May 12, 2020
New pathways in immune stimulation: targeting OX40Carolina Alves Costa Silva, Francesco Facchinetti, Bertrand Routy, et al.ESMO Open|June 4, 2020
Metastatic breast cancer and pseudocirrhosis: an unknown clinical entityDan Engelman, Michel Moreau, Antonia Lepida, et al.ESMO Open|June 4, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT studyJean-Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, et al.ESMO Open|May 10, 2020
Young patients with cancer and a digital social network: the voice beyond the clinicIrit Ben-Aharon, Tal Goshen-Lago, Ilit Turgeman, et al.ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.ESMO Open|April 22, 2020
Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancerRhode Bijlsma, Roel Wouters, Hester Wessels, et al.ESMO Open|April 10, 2020
New emerging targets in cancer immunotherapy: the role of neoantigensLeticia De Mattos-Arruda, Juan Blanco-Heredia, Carmen Aguilar-Gurrieri, et al.Pageof 183